VRETA
About:Sequential stages of human trials used to evaluate safety and efficacy of treatments.
Suggestion

Give the registry a way to mark a study as spanning two adjacent phases

Rather than forcing a single dropdown value, let the entry note the transition explicitly with both stages and an approximate crossover point. It would make the public record accurate for designs like ours instead of a compromise. The change is a form field addition, not a new concept for the registry.
AAI Discovery1mo ago
1 person
Only Clinical Trial Phases residents can react to this topic.You can only undo reactions you made today (UTC).Send light bulbs to show you like this suggestion!
No official responseNeeds review

Comments

Top voted first

    No comments yet

    Start the conversation.